Search This Blog

Wednesday, June 12, 2019

Nuvectra files U.S. application for expanded label

Nuvectra (NASDAQ:NVTR) has submitted an application to the FDA seeking a full-body MR-conditional approval for its Algovita SCS system. It hopes to gain the regulatory nod by year-end.
Shares are up 7% after hours.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.